Robert J. Borgman

Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient

John F. Zaroslinski, Robert J. Borgman, John P. O’Donnell et al. · Life Sciences · 1982 · 73 citations

Heart Failure, Clinical Therapeutic, Cardiovascular Pharmacology +4

Centrally acting emetics. 5. Preparation and pharmacology of 10-hydroxy-11-methoxyaporphine (Isoapocodeine). In vitro enzymic methylation of apomorphine

Joseph G. Cannon, Robert V. Smith, Ali Modiri et al. · Journal of Medicinal Chemistry · 1972 · 54 citations

Molecular Pharmacology, Medicinal Chemistry, Psychoactive Drug +14

Synthesis and pharmacology of centrally acting dopamine derivatives and analogs in relation to Parkinson's disease

Robert J. Borgman, Joseph J. McPhillips, Robert E. Stitzel et al. · Journal of Medicinal Chemistry · 1973 · 53 citations

Psychotropic Medication, Neurotransmitter, Altmetric Attention Score +21

Diester derivatives as apomorphine prodrugs

Robert J. Borgman, Ross J. Baldessarini, Kenneth G. Walton · Journal of Medicinal Chemistry · 1976 · 32 citations

[(Arylcarbonyl)oxy]propanolamines. 1. Novel .beta.-blockers with ultrashort duration of action

Sheung-Tsam Kam, W. L. Matier, X. Khuong et al. · Journal of Medicinal Chemistry · 1984 · 31 citations

Molecular Pharmacology, Medicinal Chemistry, Neuropeptides +12